Lataa...
Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases
Phosphodiesterase type-5 (PDE-5) is an enzyme that catalyzes the hydrolytic degradation of cyclic GMP – an essential intracellular second messenger that modulates diverse biological processes in living cells. Three selective inhibitors of PDE-5 – sildenafil, vardenafil and tadalafil – have been succ...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Pulsus Group Inc
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3206106/ https://ncbi.nlm.nih.gov/pubmed/22131856 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|